Bank of America’s Shuttle Pharmaceuticals SHPH Stock Holding History

Bank of America’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$22	–	6720
2025 Q4	$22	Hold	1	–	–	﹤0.01%	7107
2025 Q3	$28	Buy	+1	New	+$37	﹤0.01%	8127
2025 Q2	–	Hold	0	–	–	–	8291
2025 Q1	–	Hold	0	–	–	–	8213
2024 Q4	–	Hold	0	–	–	–	8022
2024 Q3	–	Hold	0	–	–	–	8030
2024 Q2	–	Hold	0	–	–	–	7985

Other funds holding SHPH

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's SHPH Position: Q1 2026 in Review

Bank of America sold out of Shuttle Pharmaceuticals (SHPH) in Q1 2026, closing a stake of 1 share — an estimated $22 sold.

Bank of America first reported a position in SHPH in Q3 2025 and held it in 2 quarters. The position peaked at $28 in Q3 2025. 8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

Bank of America reported no remaining Shuttle Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Bank of America sold 1 Shuttle Pharmaceuticals share in Q1 2026, an estimated $22.
Bank of America first reported a position in Shuttle Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Bank of America's Shuttle Pharmaceuticals position peaked at $28 in Q3 2025.
8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.